Pregabalin as adjunctive therapy for partial seizures

Epilepsia

Volumn 45, Issue SUPPL. 6, 2004, Pages 19-27

  Brodie, Martin J ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

Adjunctive therapy; Antiepileptic drugs; Clinical trials; Efficacy; Partial seizures; Pregabalin

Indexed keywords

PREGABALIN;

ACCIDENT; AMBLYOPIA; ASTHENIA; ATAXIA; CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; CONFERENCE PAPER; DIPLOPIA; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HEADACHE; HUMAN; PRIORITY JOURNAL; SIDE EFFECT; SIMPLE PARTIAL SEIZURE; SOMNOLENCE; THOUGHT DISORDER; TONIC CLONIC SEIZURE; TREMOR; VISUAL IMPAIRMENT; WEIGHT GAIN;

EID: 5344259744     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2004.455004.x     Document Type: Conference Paper

References (23)

1. Kwan P, Brodie MJ. Early identification of refractory epilepsy. New Engl J Med 2000;342:314-9.
2. Ben-Menachem E, Kugler AR. Pregabalin and epilepsy. In: Shorvon S, Fish D, Dodson E, Perruca E, eds. Treatment of epilepsy. 2nd edition. Oxford: Blackwell Publishing Ltd, Oxford (in press).
3. Ben-Menachem E, Kugler AR. Pregabalin. In: Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Antiepileptic drugs. 5th edition. Philadelphia: Lippincott Williams & Wilkins, 2002:901-5.
4. Kugler AR, Robbins JL, Strand JC, et al. Pregabalin overview: a novel CNS-active compound with anticonvulsant activity. Poster presented at the Annual Meeting of the American Epilepsy Society, Seattle, Washington, December 6-12, 2002.
5. Wilson E, Brodie MJ, Bockbrader HN, et al. Pregabalin drug interaction studies in patients with epilepsy maintained on either valproate (VPA), lamotrigine (LTG), phenytoin (PHT), or carbamazepine (CBZ). Poster presented at the 5th European Congress on Epileptology, Madrid, Spain, October 6-10, 2002.
6. Bockbrader HN, Burger PJ, Kugler AR, et al. Population pharmacokinetic (PK) analyses of commonly prescribed antiepileptic drugs (AEDs) coadministered with pregabalin (PGB) in adult patients with refractory partial seizures [Abstract]. Epilepsia 2001;42(suppl 7):84.
7. French JA, Kugler AR, Robbins JL, Knapp LE, Garofalo EA. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003;60:1631-7.
8. Arroyo S, Anhut H, Kugler AR, et al. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 2004;45:20-7.
9. Beydoun AA, Uthman BM, Ramsay RE, et al. Pregabalin add-on trial: double-blind, multicenter study in patients with partial epilepsy. Epilepsia 2000; 41(suppl 7):253-4.
10. Shorvon SD, Lowenthal A, Janz D, Bielen E, Loiseau P for the European Levetiracetam Study Group. Multicenter double-blind randomized placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia 2000;41:1179-86.
11. Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I and the United States Levetiracetam Study Group. Levetiracetam for partial seizures. Results of a double-blind randomized clinical trial. Neurology 2000;55:236-42.
12. Bares G, Walker EB, Elger CE, et al. Oxcarbazepine placebo-controlled dose-ranging trial in refractory partial epilepsy. Epilepsia 2000;41:1597-607.
13. Brodie MJ, Kugler AR, Anhut H, et al. Pregabalin adjunctive therapy in patients with partial seizures: additional efficacy analyses. Poster presented at the Annual Meeting of the American Epilepsy Society, Seattle, Washington, December 6-11, 2002.
14. Stefan H, Kugler AR, Anhut H, de Meynard C, Knapp LE. Pregabalin adjunctive therapy in patients with partial seizures. Poster presented at the Annual Meeting of the American Epilepsy Society, Seattle, Washington, December 6-11, 2002.
15. Cramer JA, Fisher R, Ben-Menachem E, French J, Mattson RH. New antiepileptic drugs: comparison of key clinical trials. Epilepsia 1999;40:590-600.
16. Perucca E, Ramsay RE, Robbins JL, Kugler AR, Anhut H, Knapp LE. Pregabalin demonstrates anticonvulsant activity onset by the second day. Poster presented at the Annual Meeting of the American Epilepsy Society, Seattle, Washington, December 6-11, 2002.
17. Greiner MJ, Kugler AR, Lee CM, Knapp LE, Garofalo EA. Pregabalin shows efficacy in reducing simple partial, complex partial, and secondarily generalized seizures [Abstract]. Epilepsia 2003; 44(suppl 9):S60.
18. th International Conference on the Mechanisms and Treatment of Neuropathic Pain. Bermuda, November 21-23, 2002.
19. th World Congress on Pain. San Diego California, August 22. 2002.
20. Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized placebo-controlled trial. Neurology 2003;60:1274-83.
21. Pande AC, Crockatt JG, Feltner DE, et al. Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry 2003;160:533-40.
22. Feltner DE, Crockatt JG, Dubovsky SJ, et al. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 2003;23:240-9.
23. Lauria-Horner BA, Pohl RB. Pregabalin: a new anxiolytic. Expert Opin Investig Drugs 2003;12:663-72.